ANDA 87514, held by Pharm Assoc. Triprolidine Hydrochloride.
As of Nov 15, 2026, ANDA 87514 (Triprolidine Hydrochloride), held by Pharm Assoc, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Triprolidine Hydrochloride1.25MG/5ML ยท syrup;oral | Triprolidine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
